The first reported robotic double transplant of a liver and kidney was performed by WashU Medicine surgeons operating in the ...

WashU Medicine researchers reduced Alzheimer’s-like neurodegeneration in mice by preventing immune cells from traveling to ...

Study identifies brain differences tied to sensory distress, often linked to anxiety and autism.

Most cancer genome studies have focused on mutations in the tumor itself and how such gene variants allow a tumor to grow unchecked. A new study, led by researchers at Washington University School of ...

Leaders across WashU Medicine foster a culture of ambition and achievement that improves the health of the region, the nation and the world. Some of these contributions leave such an indelible mark — ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

Researchers at Washington University School of Medicine in St. Louis have developed an approach to estimating when a person who is likely to develop Alzheimer’s disease, but has no cognitive symptoms, ...

The first participants in an international clinical trial aimed at preventing Alzheimer’s disease in young adults at high risk of the disease have been enrolled. The trial, led by Washington ...

Roughly 4% of the population is affected by a congenital brain malformation that has eluded researchers’ efforts to find causes and treatments. For the condition, Chiari type-1 malformation, the ...

Andrew Taylor, an emeritus trustee of Washington University in St. Louis, and his wife, Barbara, have made a $50 million gift to WashU Medicine’s neurosurgery department to enhance groundbreaking ...

A new episode of our podcast, “Show Me the Science,” has been posted. At present, these podcasts are highlighting research and patient care on the Washington University Medical Campus as our ...